Welcome to our dedicated page for Aegon Funding Company SEC filings (Ticker: AEFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aegon Funding Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aegon Funding Company's regulatory disclosures and financial reporting.
Boeren Leni reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Leni Boeren received a grant of 4,160 Common Shares on June 10, 2026 as equity compensation. The shares were awarded at a price of $0.00 per share and are subject to time-based vesting under the applicable grant agreement. After this grant, Boeren directly holds 4,160 Common Shares.
AEGON LTD. filed an initial insider ownership report for director Leni Boeren. This Form 3 establishes Boeren as a reporting insider of the company but does not list any stock holdings or transactions at this time.
Aegon is reorganizing senior leadership and selecting New York City as its future corporate headquarters as part of a planned move of its head office and legal seat to the United States. Will Fuller will be appointed President and Chief Operating Officer effective January 1, 2027, responsible for day-to-day management of Transamerica, Aegon’s International businesses and Aegon Asset Management, and will report to CEO Lard Friese. Mr. Friese will relocate to the United States at the beginning of 2027. Aegon says the New York office is expected to open in mid-2027 and will house selected corporate functions and members of the leadership team. The communication reiterates that Aegon will file a registration statement on Form F-4 and mail a definitive Proxy Statement/Prospectus ahead of an extraordinary general meeting contemplated in Q4 2026 in connection with the proposed Redomiciliation.
Aegon Ltd is reshaping its leadership and corporate structure as it prepares to redomicile to the United States and establish a new headquarters. The company will appoint Will Fuller as President and Chief Operating Officer effective January 1, 2027, putting him in charge of Transamerica, Aegon’s International businesses, and Aegon Asset Management while he reports to CEO Lard Friese. Friese will remain CEO with full responsibility for group strategy and performance and plans to relocate to the United States at the beginning of 2027. Aegon has also chosen New York City as the location for its future corporate headquarters, with an office expected to open in mid-2027 to host key corporate functions and leadership. As part of a broader corporate reorganization, Aegon intends to file a Form F-4 registration statement with the SEC that will include a Proxy Statement/Prospectus for shareholders, with an extraordinary general meeting on the proposed redomiciliation contemplated for Q4 2026.
Aegon Ltd. reports that its Annual General Meeting of Shareholders approved all items on the agenda. Shareholders approved a final dividend for 2025 of EUR 0.21 per common share, bringing the total 2025 dividend to EUR 0.40 per common share.
The meeting also approved extending Lard Friese’s term as Executive Director and Chief Executive Officer until the end of the 2030 AGM and appointed Leni Boeren to the Board of Directors. The company reiterates standard forward-looking statement cautions and provides links to full AGM resolution details on its website.
Vereniging Aegon filed an amended Schedule 13D showing beneficial ownership of 265,681,483 Aegon Ltd. common shares, representing 17.92% of the class, based on 1,482,375,744 shares outstanding as of May 27, 2026.
The filing describes a Framework Agreement between Vereniging Aegon and Aegon Ltd. Under this agreement, Vereniging Aegon will transfer EUR 500 million and certain charity agreements and interests to a new Dutch charitable foundation in a transaction referred to as the “VA Split.” The VA Split will not involve any disposition of Aegon common shares and, after it is completed, Vereniging Aegon will be renamed “Vereniging Aegon Americas.”
In addition to the common shares reported, Vereniging Aegon has sole power to vote and dispose of 327,885,200 Common Shares B. When combined with its common shares, this gives Vereniging Aegon the power to vote 32.64% of Aegon Ltd.’s total voting power.
Aegon Ltd has agreed a new framework with its largest shareholder, Vereniging Aegon, and outlined a US‑aligned governance structure linked to its planned redomiciliation to Delaware. The company proposes phasing out its staggered board so all directors stand for annual election by 2030, introducing majority voting in uncontested elections, and holding annual advisory say‑on‑pay votes.
Aegon plans to simplify its capital structure by eliminating Common Shares B and converting all outstanding Common Shares B on a 1:40 basis into a single class of common stock with equal voting rights, while authorizing a new class of preferred stock. Vereniging Aegon will be renamed Vereniging Aegon Americas and retain a pro forma 18.4% ownership position, and a new Dutch charitable entity, Stichting Aegon Fonds Nederland, will receive a EUR 500 million donation to continue and expand Dutch social initiatives.
The governance and shareholder‑relationship changes are tied to Aegon’s broader plan to move its legal seat, tax residency, accounting standards, and governance to the US, reflecting that Transamerica now represents approximately 70% of group operations. These steps, including the redomiciliation and bye‑law changes, remain conditional on shareholder approval at an extraordinary general meeting currently anticipated for Q4 2026 and on other specified conditions being met before deadlines that extend to December 2027.
Aegon Ltd. outlines a proposed governance framework linked to its planned redomiciliation and continuation as a Delaware corporation. Transamerica, its U.S. subsidiary, now represents approximately 70% of operations, so the move is intended to align headquarters, domicile, tax, accounting, and governance with its largest business.
The plan would simplify capital structure by eliminating Common Shares B and converting all outstanding Common Shares B into Common Shares on a 40-to-1 basis, leaving a single class with equal voting rights and authorizing a new class of preferred stock. Board elections would transition to annual terms, supermajority voting for shareholder-nominated directors and removals would be replaced with majority or plurality standards, and pre-emptive rights and some Dutch-style shareholder approvals would be removed in favor of Delaware law and NYSE rules.
Aegon expects to seek shareholder approval for the redomiciliation at an extraordinary general meeting contemplated for Q4 2026, after filing a Form F-4 registration statement including a Proxy Statement/Prospectus with the SEC and gathering investor input on the governance framework.
Aegon Ltd has appointed Jennifer Palmieri as Chief Human Resources Officer and member of the Executive Committee, effective June 29, 2026. She succeeds Holly Waters, who will retire as of June 1, 2026, creating a brief transition gap between the roles.
Palmieri brings more than 25 years of HR experience, including senior leadership positions at Westfield Insurance and Cigna. Aegon’s CEO highlights her role in supporting the planned transition of Aegon’s head office and legal seat to the United States and in strengthening leadership and employee engagement across the group.
Aegon Ltd. reports its 2025 financial condition under Bermuda group supervision, showing a net result of EUR 980 million, up from EUR 676 million, and an operating result of EUR 1,702 million versus EUR 1,485 million in 2024.
Insurance revenue was EUR 9,097 million compared with EUR 9,841 million. The Group Solvency Capital Requirement was EUR 6,464 million, with eligible own funds of EUR 11,901 million, resulting in a solvency ratio of 184%. Capital actions included EUR 550 million of share buybacks in 2025 and the sale of 12.5 million ASR Nederland shares for EUR 700 million, which added 13 percentage points to the group solvency ratio.